BiomarkersHumans
Longitudinal trajectories of advanced cortical diffusion‐weighted imaging measures of tissue microstructure in pre‐symptomatic autosomal dominant Alzheimer’s disease
AAIC 2025 Abstract
Abstract
Background: In Alzheimer’s disease, quantitative biomarkers of early subtle neurodegeneration are needed to identify individuals at greatest risk of imminent cognitive decline.



